Keshav Biochem Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 02-11-2024
- Paid Up Capital ₹ 3.00 Cr
as on 02-11-2024
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 Cr
as on 02-11-2024
- Revenue 116.62%
(FY 2023)
- Profit -41.36%
(FY 2023)
- Ebitda 199.20%
(FY 2023)
- Net Worth 5.77%
(FY 2023)
- Total Assets -33.68%
(FY 2023)
About Keshav Biochem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹6.00 Cr.
Narendra Kothari, Ritu Kothari, and Madhav Kothari serve as directors at the Company.
- CIN/LLPIN
U24230MH2021PTC369167
- Company No.
369167
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2021
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Keshav Biochem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Kothari  | Director | 09-Oct-2021 | Current |
| Ritu Kothari | Director | 09-Oct-2021 | Current |
| Madhav Kothari | Additional Director | Current |
Financial Performance of Keshav Biochem.
Keshav Biochem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 116.62% increase. The company also saw a substantial fall in profitability, with a 41.36% decrease in profit. The company's net worth moved up by a moderate rise of 5.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Keshav Biochem?
In 2023, Keshav Biochem had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mdk Chemicals Private LimitedActive 4 years 4 monthsNarendra Kothari and Ritu Kothari are mutual person
Keshav Hichem Private LimitedActive 29 years 7 monthsNarendra Kothari and Ritu Kothari are mutual person
Mdk Chemtex Private LimitedActive 14 years 4 monthsNarendra Kothari, Ritu Kothari and 1 more are mutual person
- Zofia Ingredients Private LimitedActive 12 years 3 months
Narendra Kothari, Ritu Kothari and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 31 Jan 2024 | ₹6.00 Cr | Open |
How Many Employees Work at Keshav Biochem?
Unlock and access historical data on people associated with Keshav Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Keshav Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Keshav Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
